Edwards Lifesciences Corp (NYSE:EW)
$ 89 -1.11 (-1.23%) Market Cap: 53.61 Bil Enterprise Value: 53.30 Bil PE Ratio: 38.35 PB Ratio: 7.53 GF Score: 98/100

Q4 2018 Edwards Lifesciences Corp Earnings Call Transcript

Jan 31, 2019 / 10:00PM GMT
Release Date Price: $56.81 (+1.00%)
Operator

Greetings, and welcome to the Edwards Lifesciences' Fourth Quarter 2018 Results Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.

It is now my pleasure to introduce your host, David Erickson, Vice President, Investor Relations. Thank you, sir. You may begin.

David K. Erickson
Edwards Lifesciences Corporation - VP of IR

Welcome, and thank you for joining us today. Just after the close of regular trading, we released our fourth quarter 2018 financial results. During today's call, we'll discuss the results included in the press release and the accompanying financial schedules, and then use the remaining time for Q&A. Our presenters on today's call are Mike Mussallem, Chairman and CEO; and Scott Ullem, CFO.

Before we begin, I'd like to remind you that during today's call, we will be making forward-looking statements that are based on estimates, assumptions and projections. These statements include, but aren't limited to, financial guidance, expectations for product opportunities, commercial trends,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot